NCT00810017 2022-05-19Phase 2 Study of Trastuzumab and Etoposide for Her2 Positive Breast CancerMedstar Health Research InstitutePhase 2 Terminated2 enrolled 3 charts
NCT01439568 2019-07-23A Study of LY2510924 in Participants With Extensive-Stage Small Cell Lung CarcinomaEli Lilly and CompanyPhase 2 Completed90 enrolled 13 charts